Literature DB >> 4186052

Five gangliosidoses.

J S O'Brien.   

Abstract

Mesh：

Substances：

Year:  1969        PMID： 4186052     DOI： 10.1016/s0140-6736(69)90524-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  A case of G M2 gangliosidosis of late onset.

Authors:  P Buxton; J N Cumings; R B Ellis; B D Lake; W G Mair; J R Roberts; E P Young
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-10       Impact factor: 10.154

2.  Clinical and enzymatic variations in G M1 generalized gangliosidosis.

Authors:  H S Singer; I A Schafer
Journal:  Am J Hum Genet       Date:  1972-07       Impact factor: 11.025

3.  Ganglioside GM2 storage diseases: hexosaminidase deficiencies in cultured fibroblasts.

Authors:  S Okada; M L Veath; J Leroy; J S O'Brien
Journal:  Am J Hum Genet       Date:  1971-01       Impact factor: 11.025

4.  Immunological studies of beta galactosidase in normal human liver and in GM1 gangliosidosis.

Authors:  M Meisler; M C Rattazzi
Journal:  Am J Hum Genet       Date:  1974-11       Impact factor: 11.025

5.  Juvenile Sandhoff disease: some properties of the residual hexosaminidase in cultured fibroblasts.

Authors:  S Wood; B G MacDougall
Journal:  Am J Hum Genet       Date:  1976-09       Impact factor: 11.025

6.  Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies.

Authors:  W G Johnson; C S Cohen; A F Miranda; S P Waran; A M Chutorian
Journal:  Am J Hum Genet       Date:  1980-07       Impact factor: 11.025
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.